MENU
+Compare
SBFM
Stock ticker: NASDAQ
AS OF
Sep 5 closing price
Price
$1.35
Change
-$0.07 (-4.90%)
Capitalization
6.17M

SBFM Sunshine Biopharma Inc Forecast, Technical & Fundamental Analysis

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals... Show more

SBFM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SBFM with price predictions
Sep 05, 2025

SBFM in upward trend: price may ascend as a result of having broken its lower Bollinger Band on September 05, 2025

SBFM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 52 cases where SBFM's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SBFM advanced for three days, in of 186 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 05, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SBFM as a result. In of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for SBFM turned negative on September 05, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .

SBFM moved below its 50-day moving average on August 29, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for SBFM crossed bearishly below the 50-day moving average on August 04, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SBFM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SBFM entered a downward trend on August 12, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.240) is normal, around the industry mean (16.653). P/E Ratio (0.001) is within average values for comparable stocks, (74.307). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.902). SBFM has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (0.026) is also within normal values, averaging (42.886).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SBFM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SBFM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
SBFM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

SBFM is expected to report earnings to fall 91.00% to -9 cents per share on November 11

Sunshine Biopharma Inc SBFM Stock Earnings Reports
Q3'25
Est.
$-0.09
Q4'24
Missed
by $1.07
Q4'23
Missed
by $4.97
Q3'23
Beat
by $0.02
Q2'23
Beat
by $0.06
The last earnings report on April 01 showed earnings per share of -100 cents, missing the estimate of 7 cents. With 70.09K shares outstanding, the current market capitalization sits at 6.17M.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
6500 Trans-Canada Highway
Phone
+1 514 426-6161
Employees
83
Web
https://www.sunshinebiopharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TZUP5.600.03
+0.54%
Thumzup Media Corporation
PGC28.90-0.15
-0.52%
Peapack-Gladstone Financial Corp
WES38.04-0.43
-1.12%
Western Midstream Partners LP
SYBT79.36-1.34
-1.66%
Stock Yards Bancorp
APLM5.16-0.32
-5.84%
Apollomics Inc

SBFM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SBFM has been loosely correlated with HNSPF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if SBFM jumps, then HNSPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SBFM
1D Price
Change %
SBFM100%
-5.24%
HNSPF - SBFM
46%
Loosely correlated
N/A
CHSYF - SBFM
30%
Poorly correlated
N/A
ELAN - SBFM
27%
Poorly correlated
+5.50%
TLRY - SBFM
27%
Poorly correlated
+3.48%
EVOK - SBFM
25%
Poorly correlated
-1.51%
More

Groups containing SBFM

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SBFM
1D Price
Change %
SBFM100%
-5.24%
Pharmaceuticals: Generic
industry (223 stocks)
15%
Poorly correlated
+2.48%